Cetera Investment Advisers
ZYNE

Cetera Investment Advisers’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Cetera Investment Advisers’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,800
Closed -$65K – 632
2019
Q4 		$65K Hold
10,800
– – 0.01% 579
2019
Q3 		$86K Hold
10,800
– – 0.01% 531
2019
Q2 		$151K Buy
+10,800
New +$125K 0.02% 502

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Cetera Investment Advisers's ZYNE Position: Q1 2020 in Review

Cetera Investment Advisers sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2020, closing a stake of 10,800 shares — an estimated $65K sold.

Cetera Investment Advisers first reported a position in ZYNE in Q2 2019 and held it in 3 quarters. The position peaked at $151K in Q2 2019. 77 funds tracked by Wall St. Rank hold ZYNE as of Q1 2020.

  • Cetera Investment Advisers reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2020 after selling out during the quarter.
  • Cetera Investment Advisers sold 10,800 Zynerba Pharmaceuticals, Inc shares in Q1 2020, an estimated $65K.
  • Cetera Investment Advisers first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2019 and held it in 3 quarters.
  • Cetera Investment Advisers's Zynerba Pharmaceuticals, Inc position peaked at $151K in Q2 2019.
  • 77 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2020.

Based on Cetera Investment Advisers's 13F filing for Q1 2020, filed 8 May 2020.